RIPE-KG · Version 1.1.0 · Resource
ripekg:publication-details/RIPEABC7D27C0BF8128FA
https://w3id.org/ripe/ripe-kg/publication-details/RIPEABC7D27C0BF8128FA
| Subject | Predicate | Object |
|---|---|---|
ripekg:evaluation/RIPEABC7D27C0BF8128FA |
prov:used |
ripekg:publication-details/RIPEABC7D27C0BF8128FAAdjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
ripekg:publication-details/RIPEABC7D27C0BF8128FAAdjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
prism:eIssn |
1745-6215 |
ripekg:publication-details/RIPEABC7D27C0BF8128FAAdjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
prism:publicationDate |
2025-04-17 |
ripekg:publication-details/RIPEABC7D27C0BF8128FAAdjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
prism:publicationName |
Trials |
ripekg:publication-details/RIPEABC7D27C0BF8128FAAdjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
dcterms:publisher |
ripekg:publisher/RIPEP13F074DA04C2917ASpringer Science and Business Media LLC |
ripekg:publication-details/RIPEABC7D27C0BF8128FAAdjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
dcterms:title |
Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
ripekg:publication-details/RIPEABC7D27C0BF8128FAAdjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
rdf:type |
http://purl.org/spar/fabio/BibliographicMetadata |
ripekg:publication-details/RIPEABC7D27C0BF8128FAAdjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
rdf:type |
rdfs:Resource |
ripekg:publication-details/RIPEABC7D27C0BF8128FAAdjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
rdf:type |
owl:Thing |
ripekg:publication-details/RIPEABC7D27C0BF8128FAAdjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
rdf:type |
ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence |
ripekg:publication-details/RIPEABC7D27C0BF8128FAAdjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
rdf:type |
ripe:PublicationDetailsPublication details |
ripekg:publication-details/RIPEABC7D27C0BF8128FAAdjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
rdf:type |
tido:Evidence |
ripekg:publication-details/RIPEABC7D27C0BF8128FAAdjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
prov:wasGeneratedBy |
ripekg:evidence-aggregation/RIPEABC7D27C0BF8128FA |
ripekg:publication-details/RIPEABC7D27C0BF8128FAAdjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEABC7D27C0BF8128FA |
ripekg:publication-details/RIPEABC7D27C0BF8128FAAdjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
ripe:concerns |
ripekg:work/10.1186%2Fs13063-025-08836-4Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
ripekg:publication-details/RIPEABC7D27C0BF8128FAAdjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEABC7D27C0BF8128FA-human-1-1 |
ripekg:publication-details/RIPEABC7D27C0BF8128FAAdjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEABC7D27C0BF8128FA-inspectai-1-1 |